Cytotoxicity of methamphetamine exposure on Sertoli cells: a pilot study with implications for male infertility.

Drug Chem Toxicol

Department of Medical Bioscience, Faculty of Natural Science, University of the Western Cape, Bellville, South Africa.

Published: March 2025

Methamphetamine (Meth), a psychoactive drug, has been shown to reduce testicular weight and decrease sperm count, indicating its potential role in contributing to male infertility. We therefore assessed Meth's effects (0.1-100 μM) on TM4 Sertoli cell viability, toxicity, and proliferation (trypan blue exclusion assay), mitochondrial activity (MA) (XTT assay), while transepithelial electrical resistance (TEER) was used to examine monolayer permeability. The acute study (only 24-hour Meth exposure) mimics recreational users and the chronic study, the Meth addicts who require daily doses (24-96 hours). Acute Meth treatment had minimal impact on TM4 Sertoli cell viability and toxicity, while chronic exposure resulted in reduced cell viability and increased toxicity in a dose-related manner. Acute exposure suppressed cell division at 72 hours, while chronic exposure suppressed cell division at both 72 and 96 hours. Long-term suppression of MA was observed for both acute and chronic Meth exposure (20 µM and 100 µM). Both acute and chronic Meth exposure affected permeability across the blood-testis barrier (BTB), which persisted for up to 96 hours. Given the pivotal role of Sertoli cells in spermatogenesis, our findings provide a two-pronged mechanism for Meth-induced male infertility and indicate that short-term exposure may have long-term effects on the germinal epithelium.

Download full-text PDF

Source
http://dx.doi.org/10.1080/01480545.2025.2471383DOI Listing

Publication Analysis

Top Keywords

male infertility
12
cell viability
12
meth exposure
12
exposure
8
sertoli cells
8
tm4 sertoli
8
sertoli cell
8
viability toxicity
8
chronic exposure
8
exposure suppressed
8

Similar Publications

Article Synopsis
  • The study aimed to explore the relationship between antisperm antibodies (ASA) and male fertility, highlighting contradictory reports on the topic.
  • The research examined 2,727 men, categorizing them based on ASA presence and analyzing its effect on semen quality and reproductive health.
  • Results showed that men with higher ASA levels had increased semen agglutination and leukocytes, indicating potential fertility issues, while smoking was linked to a higher likelihood of having pathological ASA levels.
View Article and Find Full Text PDF

Research progress on glycolipid metabolism of Sertoli cell in the development of spermatogenic cell.

Zhejiang Da Xue Xue Bao Yi Xue Ban

March 2025

Institute of Translational Medicine, Yangzhou University Medical College, Yangzhou 225009, Jiangsu Province, China.

Sertoli cells play an important role in the process of spermatogenesis by providing energy for spermatogenic cells and themselves through glycolysis and fatty acid oxidation. Abnormalities in spermatogenesis are closely related to disruptions of glucose and lipid metabolism in Sertoli cells. The metabolic environment of Sertoli cells is hypoxic, with glycolysis and fatty acid β-oxidation being the primary metabolic pathways.

View Article and Find Full Text PDF

Exploring fertility treatment add-on use, information transparency and costs in the UK: Insights from a patient survey.

Hum Fertil (Camb)

December 2025

Centre for Biostatistics, Manchester Academic Health Science Centre, Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, UK.

This study presents the findings from a UK-based survey exploring fertility treatment add-ons, treatment costs, and information transparency. The online survey, distributed via social media, targeted current and prospective IVF patients, yielding 304 eligible responses. Results indicate an increase in the use of fertility treatment add-ons compared to previous data.

View Article and Find Full Text PDF

A novel homozygous frameshift mutation in MCM8 causes primary gonadal dysgenesis in both genders.

J Assist Reprod Genet

March 2025

Department of Reproductive Medicine, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210002, Jiangsu, China.

Purpose: We aimed to demonstrate the genetic factors of primary gonadal dysgenesis in a consanguineous family characterized by underdeveloped testes and non-obstructive azoospermia (NOA) in a male and primary amenorrhoea and primary ovarian insufficiency (POI) in a female.

Methods: DNA was extracted from the male proband with infertility from the consanguineous family for whole-exome sequencing and bioinformatics analysis to screen for potential pathogenic genes and mutations. Sanger sequencing was used for further validation of his family pedigree.

View Article and Find Full Text PDF

The Y chromosome: male reproduction and beyond.

Fertil Steril

March 2025

Dept. of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy; Department of Andrology, Fundació Puigvert, Universitat Autònoma de Barcelona, Instituto de Investigaciones Biomédicas Sant Pau (IIB-Sant Pau), Barcelona, Catalonia, Spain.

The crucial role of Y chromosome genes in male gonadal determination and reproductive fitness has been recognized for decades. Y chromosome microdeletions are the most common molecular genetic causes of azoospermia and severe spermatogenic impairment. Since the late 1990s, screening for these microdeletions has become a routine part of the diagnostic work-up of severe male factor infertility.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!